Sunday, Aug 01, 2021
Focus on the big picture

Pfizer agrees to pay $345 million to resolve EpiPen lawsuit

Reuters, 17 Jul 2021
Pfizer has agreed to pay $345 million to resolve claims by consumers who claim they overpaid for EpiPens due to anticompetitive practices by the drugmaker and Mylan, the company that markets the emergency allergy treatment.

#Pfizer #Mylan #EpiPen #News #Reuters


Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.

Get the latest news on:
Follow Reuters on Facebook:
Follow Reuters on Twitter:
Follow Reuters on Instagram:
Related Articles